Skip to main content

Medicus Pharma Ltd.

MDCX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001997296

No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesMDCXW

Q3 2025 vs. Q2 2025

How the institutions holding Medicus Pharma Ltd. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of MDCX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders2120−1
Shares2.21M2.12M−86.6K (−3.9%)
Value$6.60M$4.91M−$1.69M (−25.6%)

New holders (7)

Institutions that held Medicus Pharma Ltd. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to MDCX in Q3 2025
InstitutionSharesValue% of portfolio
Bryn Mawr Trust Co25,622$59.3K0.00%
Brave Asset Management Inc20,000$46.3K0.01%
LPL Financial LLC18,751$43.4K0.00%
Commonwealth Equity Services, LLC10,882$25.0K0.00%
FNY Investment Advisers, LLC1,000$2.00K0.00%
EverSource Wealth Advisors, LLC300$6950.00%
Citigroup Inc222$5140.00%

Sold out (8)

Institutions that held Medicus Pharma Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of MDCX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Guyasuta Investment Advisors Inc76,911$230.0K
Verition Fund Management LLC53,385$159.6K
SeaCrest Wealth Management, LLC46,624$139.4K
Citadel Advisors LLC41,099$122.9K
Jane Street Group, LLC13,788$41.2K
HRT Financial LP11,099$33.0K
Raymond James Financial Inc500$1.50K
Parkside Financial Bank & Trust400$1.20K